Back
Protagonist Therapeutics, Inc. Stock Price Chart
Share Price Moved. Momentum Hasn't Slowed.
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Buy
63
PTGX
Protagonist Therapeutics, Inc.
Last Price:
$95.24
Seasonality Move:
37.92%
7 Day Trial
ALL ACCESS PASS
$
7
14K Investors Got In Earlier. You Still Can.
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PTGX is experiencing buying pressure, which is a positive indicator for future bullish movement.
Protagonist Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 90.11 | Buy |
| 20-day SMA: | 87.86 | Buy |
| 50-day SMA: | 80.91 | Buy |
| 200-day SMA: | 59.34 | Buy |
| 8-day EMA: | 90.88 | Buy |
| 20-day EMA: | 87.79 | Buy |
| 50-day EMA: | 81.09 | Buy |
| 200-day EMA: | 62.97 | Buy |
Protagonist Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.35 | Buy |
| Relative Strength Index (14 RSI): | 71.3 | Buy |
| Chaikin Money Flow: | 1259225 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (83.52 - 90.38) | Buy |
| Bollinger Bands (100): | (56.74 - 82.44) | Buy |
Protagonist Therapeutics, Inc. Technical Analysis
| Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Protagonist Therapeutics, Inc. Stock
Is Protagonist Therapeutics, Inc. Stock a Buy?
-
Protagonist Therapeutics, Inc. share price is 95.35 while PTGX 8-day simple moving average is 90.11, which is a Buy signal.
-
The stock price of PTGX is 95.35 while Protagonist Therapeutics, Inc. 20-day SMA is 87.86, which makes it a Buy.
-
Protagonist Therapeutics, Inc. 50-day simple moving average is 80.91 while PTGX share price is 95.35, making it a Buy technically.
-
PTGX stock price is 95.35 and Protagonist Therapeutics, Inc. 200-day simple moving average is 59.34, creating a Buy signal.
PTGX Technical Analysis vs Fundamental Analysis
Buy
63
Protagonist Therapeutics, Inc. (PTGX)
is a Buy
Is Protagonist Therapeutics, Inc. a Buy or a Sell?
-
Protagonist Therapeutics, Inc. stock is rated a BuyThe current Protagonist Therapeutics, Inc. [PTGX] share price is $95.35. The Score for PTGX is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
Protagonist Therapeutics, Inc. Stock Info
Market Cap:
6B
Price in USD:
95.35
Share Volume:
1.3M
Protagonist Therapeutics, Inc. 52-Week Range
52-Week High:
95.39
52-Week Low:
33.70
Buy
63
Protagonist Therapeutics, Inc. (PTGX)
is a Buy
Protagonist Therapeutics, Inc. Share Price Forecast
-
What is the Protagonist Therapeutics, Inc. stock price today?The Protagonist Therapeutics, Inc. stock price is 95.35 USD today.
-
Will PTGX stock go up or go down?Protagonist Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Protagonist Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Protagonist Therapeutics, Inc. is not overvalued.
Is Protagonist Therapeutics, Inc. Stock a Buy?
-
Protagonist Therapeutics, Inc. share price is 95.35 while PTGX 8-day exponential moving average is 90.88, which is a Buy signal.
-
The stock price of PTGX is 95.35 while Protagonist Therapeutics, Inc. 20-day EMA is 87.79, which makes it a Buy.
-
Protagonist Therapeutics, Inc. 50-day exponential moving average is 81.09 while PTGX share price is 95.35, making it a Buy technically.
-
PTGX stock price is 95.35 and Protagonist Therapeutics, Inc. 200-day simple moving average is 62.97, creating a Buy signal.
Fundamental Analysis of Protagonist Therapeutics, Inc.
Is Protagonist Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $1.12 per share, a decrease next quarter of $0.00 per share, a decrease this year of $4.50 per share, and an increase next year of $2.93 per share.
Technical Analysis of Protagonist Therapeutics, Inc.
Should I short Protagonist Therapeutics, Inc. stock?
-
PTGX Moving Average Covergence Divergence (MACD) indicator is 3.35, suggesting Protagonist Therapeutics, Inc. is a Buy
-
Protagonist Therapeutics, Inc. Relative Strength Index (RSI) is 71.3, which suggest Protagonist Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Protagonist Therapeutics, Inc. is (83.52 - 90.38), which suggest Protagonist Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Protagonist Therapeutics, Inc. is (56.74 - 82.44), which suggest Protagonist Therapeutics, Inc. is a Buy
* Protagonist Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.